Journal Logo
JOURNAL OF PHARMACOLOGY AND BIOMEDICINE
ISSN.2456-8244
Editor-in-Chief
Dr.Richa Mishra Online ISSN
2456-8244 Publisher
RB-Science Abbreviation
J. Pharmacol. Biomed
ABSTRACT

Naringenin, a naturally occurring flavanone predominantly found in citrus fruits, exhibits diverse pharmacological activities including antioxidant, anti-inflammatory, anticancer, cardioprotective, and neuroprotective effects. Despite these promising biological properties, the clinical translation of naringenin is severely limited by its poor aqueous solubility, extensive first-pass metabolism, low intestinal permeability, and rapid systemic elimination, resulting in low oral bioavailability. Nanoformulation-based drug delivery systems have emerged as effective strategies to overcome these limitations by enhancing solubility, protecting the drug from degradation, improving absorption, and enabling controlled or targeted delivery. This review comprehensively discusses various nano-enabled delivery platforms developed for naringenin, including polymeric nanoparticles, lipid-based carriers, nanoemulsions, nanosuspensions, phytosomes, and hybrid systems. Mechanistic insights into bioavailability enhancement, pharmacokinetic improvements, and therapeutic implications are critically analysed. The review highlights current challenges and future prospects for translating naringenin nanoformulations into clinical applications.

Articles Details

NAMES:

ONLINE ISSN:2456-8244

Keywords: Naringenin, Nanoformulation, Bioavailability, Nanoparticles, Lipid-based delivery, Phytosomes

DOI:

REFERENCES

Bhandari, P., et al. (2023) Enhanced bioavailability and brain targeting of naringenin via coated PLGA 
nanoparticles, PubMed. (PubMed) 
Bhandari, P., Kumar, V., Sharma, R. and Jain, A. (2023) Enhanced bioavailability and brain 
targeting of naringenin via PLGA nanoparticles. International Journal of Pharmaceutics, 622, Article ID 
121873. 

Bhia, M., Motallebi, M., Abadi, B., Zarepour, A., Pereira-Silva, M., Saremnejad, F., Santos, A.C., 
Zarrabi, A., Melero, A., Jafari, S.M., et al. (2021) Naringenin nano-delivery systems and their therapeutic 
applications, Pharmaceutics, 13(2), 291. (MDPI) 
Bhia, M., Motallebi, M., Abadi, B., Zarepour, A., Pereira-Silva, M., Saremnejad, F., Santos, A.C., 
Zarrabi, A., Melero, A. and Jafari, S.M. (2021) Naringenin nano-delivery systems and therapeutic 
applications. Pharmaceutics, 13(2), Article ID 291. 
Cheng, Y., Luo, L., Wang, Y. and Li, J. (2021) Chitosan-coated polymeric nanoparticles of 
naringenin for oral delivery. Carbohydrate Polymers, 262, Article ID 117940. 
Djebbar, R., Bensouici, C., Benkhaled, A. and Hadjadj, M. (2024) Comparative bioavailability of 
naringenin nano-carriers. Journal of Drug Delivery and Therapeutics, 14(10), pp. 129–136. 
Djebbar, R., et al. (2024) Comparative analysis of naringenin nano-carriers PLA/PVA and zein/pectin for 
bioavailability, Journal of Drug Delivery & Therapeutics, 14(10), 129-136. (Drug Delivery Journal) 
Gupta, S., Mishra, A. and Singh, P. (2020) Phytosome-based delivery of naringenin. Journal of Herbal 
Medicine, 24, Article ID 100392. 
Huang, Y., Zhang, Y., Chen, X. and Li, Z. (2020) Liposomal naringenin for anticancer therapy. 
Drug Delivery, 27(1), pp. 173–183. 
International Journal of Applied Pharmaceutics (2025) SNEDDS of naringenin: formulation and 
pharmacokinetics. International Journal of Applied Pharmaceutics, 17(1), pp. 45–53. 
Khan, R. and Jain, A. (2025) Nanostructured lipid carriers of naringenin. Colloids and Surfaces B: 
Biointerfaces, 234, Article ID 113045. 
Khan, S., Ahmad, M. and Rizvi, S.M.D. (2022) PLGA nanoparticles for sustained delivery of 
naringenin. European Journal of Pharmaceutical Sciences, 168, Article ID 106044. 
Kumar, A., Sharma, S. and Verma, R. (2019) Solid lipid nanoparticles of naringenin. Drug 
Development and Industrial Pharmacy, 45(7), pp. 1135–1144. 
Li, J., Wang, X. and Zhang, T. (2019) Gelatin nanoparticles for oral delivery of flavonoids. AAPS 
PharmSciTech, 20, Article ID 187. 
Liang, J., Yan, H., Zhang, J. and Wang, Y. (2016) Liposomal formulation improves oral 
bioavailability of naringenin. Journal of Analytical Science and Technology, 7, Article ID 12. 
Luo, Y., Teng, Z., Wang, Q. and Zhang, Y. (2021) Zein-based nanoparticles for naringenin 
delivery. Food Chemistry, 345, Article ID 128800. 
Modi, P., Choudhury, P.K. and Sharma, M. (2025) Phytosome based drug delivery of naringenin and 
naringin: development, characterization, in vivo evaluation, Asian Journal of Pharmaceutical Research & 
Development. (Ajprd) 

Patel, R., Patel, M. and Bhatt, D. (2020) Oral solid lipid nanoparticles of naringenin. Journal of 
Pharmaceutical Sciences, 109(6), pp. 1891–1899. 
Rajamani, S. (2019) Pharmacokinetic and tissue distributions of naringenin and naringenin nanosuspension, 
Asian Journal of Pharmaceutics. (Asian Journal of Pharmaceutics) 
Rajamani, S. (2019) Pharmacokinetics of naringenin nanosuspension. Asian Journal of Pharmaceutics, 
13(4), pp. 311–318.